Phase 1 Study of ACR-2316 in Specific Advanced Solid Tumors (NCT06667141)
ACR-2316-101: Phase 1 Study of ACR-2316 in Subjects With Advanced Solid Tumors
🩺 Plain-English Summary (8th-Grade Level)
This is a first in-human, Open-label Phase 1 study to assess the safety of ACR-2316 for the treatment of subjects with specific, histologically confirmed, locally advanced, recurrent or metastatic solid tumors.
Who can join: Review the eligibility criteria below.
Location: HonorHealth Research Institute — Phoenix, Arizona
Age range: 18 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (15 Sites)
- HonorHealth Research Institute — Phoenix, Arizona
- Precision NextGen Oncology & Research Center — Beverly Hills, California
- Hoag Memorial Hospital Presbyterian — Newport Beach, California
- Denver Health One — Denver, Colorado
- Florida Cancer Specialist — Sarasota, Florida
- Beth Israel Deaconess Medical Center — Boston, Massachusetts
- University of Michigan — Ann Arbor, Michigan
- Roswell Park Comprehensive Cancer Center — Buffalo, New York
- Montefiore Medical Centre — The Bronx, New York
- Carolina BioOncology Institute — Huntersville, North Carolina
- Rhode Island Hospital — Providence, Rhode Island
- Tennessee Oncology — Franklin, Tennessee
- The University of Texas MD Anderson Cancer Center — Houston, Texas
- NEXT Oncology — San Antonio, Texas
- Next Virginia — Fairfax, Virginia
📞 Contact the Study Coordinator
Phone: (617) 207-8979
Email: ACR-2316ClinicalTrial@acrivon.com
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
Explore by condition: All Specific Advanced Solid Tumors clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.